Stay updated with breaking news from Rev dis primers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for ....
Study Reveals LEMS Often Goes Undiagnosed in U.S. Patients with Small Cell Lung CancerCORAL GABLES, Fla., Aug. 16, 2023 Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric. -Today at 10:57 am- MarketScreener ....
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.